This inventor holds 3 USPTO granted patents. Top assignees: Institute for Basic Science, The Catholic University of Korea Industry-Academic, Snr R&db Foundation. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 99 
2 out of 2 
1 out of 1 
Years Active: 2017-2022
Title: Sin-Jung Park: Innovator in Nanotechnology and Pharmaceutical Applications
Introduction
Sin-Jung Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of nanotechnology, particularly in the development of innovative pharmaceutical compositions. With a total of three patents to his name, Park's work focuses on enhancing drug delivery systems and therapeutic methods.
Latest Patents
One of Sin-Jung Park's latest patents is titled "Dendrimer-exosome hybrid nanoparticles as a delivery platform." This invention describes hybrid nanoparticles that consist of exosomes loaded with one or more nanoparticle dendrimers. The patent also includes pharmaceutical compositions that utilize these hybrid nanoparticles and outlines methods for their production. Additionally, it describes a method for treating human subjects by administering the aforementioned hybrid nanoparticles.
Another notable patent is "Self-assembled pharmaceutical composition for photodynamic therapy." This invention relates to a nanoformulated self-assembled pharmaceutical composition designed for photodynamic therapy. It comprises a photosensitizer, a ligand A that separates at a specific pH range, and a ligand B whose surface charge changes at a specific pH range. The patent also details a method for manufacturing this innovative composition.
Career Highlights
Sin-Jung Park has worked at esteemed institutions, including The Catholic University of Korea and the Institute for Basic Science. His research has significantly advanced the understanding and application of nanotechnology in medicine.
Collaborations
Throughout his career, Park has collaborated with notable colleagues such as Taeghwan Hyeon and Kun Na. These partnerships have further enriched his research and contributed to the development of groundbreaking technologies.
Conclusion
Sin-Jung Park is a distinguished inventor whose work in nanotechnology and pharmaceutical applications has the potential to revolutionize drug delivery and treatment methods. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile